All articles
How Many Units Is 2.5 mg of Tirzepatide? A Units to mg Guide
Reading time:
9 mins
Weight loss

Units Convert Back to Milligrams With the Same Math
Sometimes the question runs backward: how many mg is 20 units of tirzepatide? Flip the formula. Divide your units by 100 to get milliliters, then multiply by your vial’s concentration in mg/mL (1). At an example 10 mg/mL, 20 units is 0.2 mL, which is 2 mg.
This chart covers the reverse searches, from 25 units of tirzepatide to how many mg is 50 units of tirzepatide. Again, these are example concentrations only. Concentration differs between pharmacies and vials, so always follow your provider and the label on your vial (2).
Units on a U-100 syringe | Volume | Example 5 mg/mL | Example 10 mg/mL | Example 20 mg/mL |
20 units | 0.2 mL | 1 mg | 2 mg | 4 mg |
25 units | 0.25 mL | 1.25 mg | 2.5 mg | 5 mg |
30 units | 0.3 mL | 1.5 mg | 3 mg | 6 mg |
40 units | 0.4 mL | 2 mg | 4 mg | 8 mg |
50 units | 0.5 mL | 2.5 mg | 5 mg | 10 mg |
So 50 units of tirzepatide is 2.5 mg, 5 mg, or 10 mg, depending on the vial. That fourfold spread is exactly why a units number means nothing without your concentration next to it.
Branded Tirzepatide Is Measured in mg and mL, Not Units
FDA-approved tirzepatide comes in fixed strengths. Zepbound and Mounjaro single-dose pens and vials each hold one dose in 0.5 mL, at 2.5, 5, 7.5, 10, 12.5, or 15 mg (3,4). Both labels start at 2.5 mg once weekly for four weeks, raise the dose in 2.5 mg steps no sooner than every four weeks, and cap it at 15 mg weekly in adults (3,4).
Here’s the detail most guides miss. Zepbound’s label also lists a four-dose KwikPen in which each 2.5 mg dose is 0.6 mL, not 0.5 mL (3). The label tells vial users to choose a 1 mL syringe that can measure either a 0.5 mL or a 0.6 mL dose (3). Same drug, same 2.5 mg, two volumes.
Product | Regulatory status | How a 2.5 mg dose is measured |
Zepbound single-dose pen or vial | FDA-approved | 2.5 mg in 0.5 mL (3) |
Zepbound KwikPen (four doses) | FDA-approved | 2.5 mg in 0.6 mL, dialed on the pen (3) |
Mounjaro single-dose pen or vial | FDA-approved | 2.5 mg in 0.5 mL (4) |
Compounded tirzepatide vial | Not FDA-approved | Varies by pharmacy and vial (2,5) |
For a full schedule, see this guide to Mounjaro dosing.
Compounded Tirzepatide Is Drawn in Units Because Vials Differ
Compounded tirzepatide is made by a compounding pharmacy rather than sold as an FDA-approved brand, and compounded GLP-1 injections often come in multiple-dose vials drawn with an insulin syringe (2,5). Compounded medications are not approved or evaluated by the FDA for safety, effectiveness, or quality. FDA states plainly that it does not review compounded drugs for safety, effectiveness, or quality before they are sold (5).
Because each pharmacy may choose its own concentration, your units can look very different from a friend’s, or from your own last vial (2). A change in pharmacy, strength, or vial size can change the units even when your mg dose stays the same.
So read every new label as if it’s your first. Compare the mg/mL on the vial with the mg/mL on your instructions. If they don’t match, don’t guess.
You can check your eligibility to see whether tirzepatide treatment through Mochi Health may be an option for you. If it is, affiliated Mochi Medical providers decide whether a medication fits you and give you dosing instructions for the specific product you receive.
FDA Has Linked Unit Mix-Ups to Serious Overdoses
Confusion between milliliters, milligrams, and units has sent people to the hospital. In a July 2024 alert, FDA described reports in which patients told to draw 5 units on a U-100 syringe drew 50 units instead (2). That’s ten times the intended dose.
FDA also reported that patients measuring from multiple-dose vials gave themselves five to 20 times more than intended (2). Some errors came from the other side: providers who miscalculated a conversion, producing doses five to 10 times too high (2). FDA has received reports of adverse events tied to dosing errors, some requiring hospitalization (5).
That alert concerned compounded semaglutide, a different medication. The math trap is identical for compounded tirzepatide, though, since both are drawn by units from vials whose concentration varies (2,5).
The fix is not more confidence. It’s a second check. FDA encourages patients to talk with their health care provider or compounder about how to measure and give the intended dose (2,5).
Five Checks Before You Draw Your Dose
A careful routine takes under a minute and catches most mistakes. These steps don’t replace your provider’s instructions. They help you confirm you’re following them.
Find the concentration on your vial label, written in mg/mL, and confirm it matches your written instructions (2).
Confirm your syringe is a U-100 insulin syringe and note its size, such as 0.3, 0.5, or 1 mL (1).
Run the formula yourself, mg ÷ mg/mL × 100, and compare it with the units your provider wrote down.
If your answer differs, or lands at a fraction you can’t measure, call your pharmacist or provider before injecting.
Use a new sterile needle and syringe every time, and rotate where to inject among your abdomen, thigh, and upper arm (5,6).
There Is No Standard Number of Units for Weight Loss
People often search how many units of tirzepatide for weight loss, hoping for a single target. There isn’t one. A dose is set in milligrams by your provider, and the units follow from your vial (2,3).
For Zepbound, the label’s weight-reduction maintenance doses are 5 mg, 10 mg, or 15 mg weekly (3). You reach them by starting at 2.5 mg and stepping up by 2.5 mg no faster than every four weeks (3). The 2.5 mg starting dose is meant for getting your body used to the drug, not as a maintenance dose (3). Your provider weighs your response and side effects before moving up a dose.
FDA has also flagged reports of people prescribed compounded tirzepatide at doses beyond what the FDA-approved label describes (5).
Never change your units on your own. Not even by a few lines.
Tirzepatide Carries a Boxed Warning for Thyroid C-Cell Tumors
Zepbound and Mounjaro carry a boxed warning for risk of thyroid C-cell tumors (3,4). In rats, tirzepatide caused thyroid C-cell tumors, and it is not known whether it causes them in people (3,6). Tirzepatide should not be used if you or a family member have had medullary thyroid carcinoma, or if you have multiple endocrine neoplasia syndrome type 2 (3). A provider will discuss this warning with you before you start.
Zepbound’s label also lists warnings for severe stomach and bowel side effects, kidney injury from dehydration, gallbladder disease, pancreatitis, allergic reactions, and low blood sugar (3). The most common side effects include nausea, vomiting, diarrhea, constipation, and decreased appetite (6).
Call your provider right away for severe stomach pain that won’t go away, a lump or swelling in your neck, or trouble swallowing (6). If you think you drew too much, contact your provider promptly (2).
Learn more about tirzepatide side effects and how they’re managed.
The Bottom Line
So how many units is 2.5 mg of tirzepatide? It’s 50 units at an example 5 mg/mL, 25 units at 10 mg/mL, and 12.5 units at 20 mg/mL on a U-100 syringe (1). Your real answer comes from one number on your vial label: the concentration.
Use the formula to understand your instructions, not to write them. Concentration differs between pharmacies and vials, so always follow your own provider’s instructions and the label on your vial, and ask your pharmacist or provider if your units don’t match (2).
If you’re exploring tirzepatide for weight loss, you can check your eligibility through Mochi Health. A licensed provider decides whether treatment is appropriate for you.
FAQs
How Many mg Is 20 Units of Tirzepatide?
Twenty units on a U-100 syringe is 0.2 mL (1). That’s 1 mg at an example 5 mg/mL, 2 mg at 10 mg/mL, or 4 mg at 20 mg/mL. Check the mg/mL on your own vial and confirm with your provider or pharmacist.
How Many mg Is 40 Units of Tirzepatide?
Forty units is 0.4 mL (1). That works out to 2 mg at an example 5 mg/mL, 4 mg at 10 mg/mL, or 8 mg at 20 mg/mL. Your provider’s written dose and your vial label are what count.
What Happens if You Inject Too Many Units?
FDA has received reports of adverse events, some requiring hospitalization, that may be related to dosing errors with compounded GLP-1 drugs (2,5). Contact your provider or pharmacist right away, and seek emergency care for severe symptoms.
References
MedlinePlus Medical Encyclopedia. Giving an insulin injection. National Library of Medicine. Accessed November 18, 2026. MedlinePlus insulin injection
US Food and Drug Administration. FDA alerts health care providers, compounders and patients of dosing errors associated with compounded injectable semaglutide products. July 26, 2024. FDA dosing errors alert
Eli Lilly and Company. ZEPBOUND (tirzepatide) injection, for subcutaneous use. Prescribing information. DailyMed, National Library of Medicine. Revised August 2026. Zepbound label
Eli Lilly and Company. MOUNJARO (tirzepatide) injection, for subcutaneous use. Prescribing information. DailyMed, National Library of Medicine. Revised August 2026.
US Food and Drug Administration. FDA’s concerns with unapproved GLP-1 drugs used for weight loss. Content current as of October 1, 2026.
MedlinePlus Drug Information. Tirzepatide injection. National Library of Medicine. Accessed November 18, 2026.
This article is for informational purposes only and does not constitute medical advice. Always consult with a qualified healthcare provider before starting, stopping, or changing any medication or treatment plan. Compounded tirzepatide, Zepbound, and Mounjaro require a written prescription from a licensed provider. Speak with a provider to determine if compounded tirzepatide, Zepbound, or Mounjaro is appropriate for you. Zepbound is FDA-approved, with a reduced-calorie diet and increased physical activity, to reduce excess body weight and maintain weight reduction in certain adults with obesity or overweight, and to treat moderate to severe obstructive sleep apnea in adults with obesity. Mounjaro is FDA-approved, with diet and exercise, to improve blood sugar control in adults and children 10 years and older with type 2 diabetes. Zepbound and Mounjaro carry a boxed warning for risk of thyroid C-cell tumors that a provider will discuss with you. Compounded medications are not approved or evaluated by the FDA for safety, effectiveness, or quality. Individual results are not guaranteed and may vary from person to person. All professional medical services are provided by licensed physicians and clinicians affiliated with independently owned and operated professional practices. Mochi Health Corp. provides administrative and technology services to affiliated medical practices it supports, and does not provide any professional medical services itself.
Share this post
Weight loss
More articles










